BioLine RX Ltd (BLRX) — Defensive Interval Ratio
BioLine RX Ltd (BLRX) has a Defensive Interval Ratio of 462 days as of September 2025. Defensive assets of ILA17.30 Million (cash ILA-, short-term investments ILA17.30 Million, receivables ILA0.00) cover 462 days of daily cash needs of ILA37.45K/day. Check BioLine RX Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BioLine RX Ltd Defensive Interval Ratio (2005–2024)
This chart shows how BioLine RX Ltd's Defensive Interval Ratio has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 462 days, meaning defensive assets of ILA17.30 Million can fund 462 days of operations without new revenue. Also explore BioLine RX Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for BioLine RX Ltd (2005–2024)
The table below presents the year-by-year Defensive Interval Ratio for BioLine RX Ltd from 2005 to 2024, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BioLine RX Ltd (BLRX) total market value.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 308 days | ILA12.99 Million | ILA42.21K/day | ILA- | ILA9.13 Million | ▼ -29 days |
| 2023 | 337 days | ILA39.45 Million | ILA117.22K/day | ILA- | ILA38.74 Million | ▼ -1072 days |
| 2022 | 1409 days | ILA41.22 Million | ILA29.26K/day | ILA- | ILA40.49 Million | ▼ -254 days |
| 2021 | 1663 days | ILA44.29 Million | ILA26.63K/day | ILA- | ILA44.15 Million | ▲ +1461 days |
| 2020 | 202 days | ILA5.90 Million | ILA29.15K/day | ILA- | ILA5.76 Million | ▼ -493 days |
| 2019 | 696 days | ILA22.80 Million | ILA32.79K/day | ILA- | ILA22.19 Million | ▼ -823 days |
| 2018 | 1518 days | ILA28.09 Million | ILA18.50K/day | ILA- | ILA26.75 Million | ▼ -923 days |
| 2017 | 2441 days | ILA44.96 Million | ILA18.42K/day | ILA- | ILA44.37 Million | ▼ -886 days |
| 2016 | 3328 days | ILA33.38 Million | ILA10.03K/day | ILA- | ILA33.15 Million | ▼ -1602 days |
| 2015 | 4930 days | ILA42.41 Million | ILA8.60K/day | ILA- | ILA42.12 Million | ▲ +1175 days |
| 2014 | 3755 days | ILA29.85 Million | ILA7.95K/day | ILA- | ILA28.85 Million | ▲ +2472 days |
| 2013 | 1282 days | ILA10.54 Million | ILA8.22K/day | ILA- | ILA9.29 Million | ▲ +1074 days |
| 2012 | 208 days | ILA3.67 Million | ILA17.61K/day | ILA- | ILA3.07 Million | ▼ -780 days |
| 2011 | 988 days | ILA18.29 Million | ILA18.51K/day | ILA- | ILA17.28 Million | ▲ +510 days |
| 2010 | 478 days | ILA29.06 Million | ILA60.80K/day | ILA- | ILA28.04 Million | ▲ +123 days |
| 2009 | 355 days | ILA40.06 Million | ILA112.96K/day | ILA- | ILA- | ▼ -4 days |
| 2008 | 358 days | ILA36.64 Million | ILA102.27K/day | ILA- | ILA30.89 Million | ▲ +291 days |
| 2007 | 67 days | ILA4.53 Million | ILA67.44K/day | ILA- | ILA3.27 Million | ▼ -84 days |
| 2006 | 151 days | ILA3.43 Million | ILA22.72K/day | ILA- | ILA2.80 Million | ▲ +45 days |
| 2005 | 106 days | ILA1.33 Million | ILA12.50K/day | ILA- | ILA- | — |